North America Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type (Post-exposure Prophylaxis, and Pre-exposure prophylaxis), By End User, By Application (Human, and Animal), By Product Type, By Country and Growth Forecast, 2023 - 2030

The North America Rabies Vaccine Market would witness market growth of 4.0% CAGR during the forecast period (2023-2030).

The US market dominated the North America Rabies Vaccine Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $384.4 Million by 2030. The Canada market is experiencing a CAGR of 6.4% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.4% during (2023 - 2030).

One key strategy for controlling rabies involves mass vaccination campaigns targeting domestic animals, particularly dogs. Dogs are the main reservoirs of the rabies virus, and widespread vaccination helps to interrupt the transmission cycle between humans and animals. Vaccinating a significant proportion of the canine population can dramatically reduce the incidence of rabies in animals and humans.

Oral rabies vaccination (ORV) is a unique and innovative approach to controlling the spread of rabies in wildlife populations. ORV involves distributing vaccine-laden baits in targeted areas to reach carnivorous wildlife species that may act as reservoirs for the virus. This method has been employed to prevent the spillover of rabies from wildlife to domestic animals and humans, contributing to the overall reduction of rabies cases.

Canada has been actively implementing wildlife rabies control programs, especially in regions where rabies is prevalent among wildlife species such as foxes, raccoons, and bats. The geographical coverage of ORV programs in Canada has expanded over time. Continuous efforts to reach a broader range of wildlife habitats contribute to more extensive control of rabies, reducing the risk of spillover to domestic animals and humans in Canada. ORV is often integrated with other control measures, such as surveillance, pet vaccination campaigns, and public health initiatives in Canada. The comprehensive approach maximizes the impact of rabies control efforts in Canada. Hence, the factors mentioned above will drive the regional market growth.

Free Valuable Insights: The Rabies Vaccine Market is Predict to reach USD 1.6 Billion by 2030, at a CAGR of 4.5%

Based on Prophylaxis Type, the market is segmented into Post-exposure Prophylaxis, and Pre-exposure prophylaxis. Based on End User, the market is segmented into Hospitals, Veterinary Clinics, and Others. Based on Application, the market is segmented into Human, and Animal. Based on Product Type, the market is segmented into Chick Embryo Cells Rabies Vaccine, Human Diploid Cell Vaccine, Vero cell rabies vaccine, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Limited
• Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
• Elanco Animal Health, Inc.
• Zoetis, Inc.
• Merck & Co., Inc.
• Novartis AG
• Bharat Biotech Ltd.
• Sanofi S.A.
• Virbac

North America Rabies Vaccine Market Report Segmentation

By Prophylaxis Type

• Post-exposure Prophylaxis
• Pre-exposure prophylaxis

By End User

• Hospitals
• Veterinary Clinics
• Others

By Application

• Human
• Animal

By Product Type

• Chick Embryo Cells Rabies Vaccine
• Human Diploid Cell Vaccine
• Vero cell rabies vaccine
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Rabies Vaccine Market, by Prophylaxis Type
1.4.2 North America Rabies Vaccine Market, by End User
1.4.3 North America Rabies Vaccine Market, by Application
1.4.4 North America Rabies Vaccine Market, by Product Type
1.4.5 North America Rabies Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Rabies Vaccine Market by Prophylaxis Type
4.1 North America Post-exposure Prophylaxis Market by Region
4.2 North America Pre-exposure prophylaxis Market by Region

Chapter 5. North America Rabies Vaccine Market by End User
5.1 North America Hospitals Market by Country
5.2 North America Veterinary Clinics Market by Country
5.3 North America Others Market by Country

Chapter 6. North America Rabies Vaccine Market by Application
6.1 North America Human Market by Country
6.2 North America Animal Market by Country

Chapter 7. North America Rabies Vaccine Market by Product Type
7.1 North America Chick Embryo Cells Rabies Vaccine Market by Country
7.2 North America Human Diploid Cell Vaccine Market by Country
7.3 North America Vero Cell Rabies Vaccine Market by Country
7.4 North America Others Market by Country

Chapter 8. North America Rabies Vaccine Market by Country
8.1 US Rabies Vaccine Market
8.1.1 US Rabies Vaccine Market by Prophylaxis Type
8.1.2 US Rabies Vaccine Market by End User
8.1.3 US Rabies Vaccine Market by Application
8.1.4 US Rabies Vaccine Market by Product Type
8.2 Canada Rabies Vaccine Market
8.2.1 Canada Rabies Vaccine Market by Prophylaxis Type
8.2.2 Canada Rabies Vaccine Market by End User
8.2.3 Canada Rabies Vaccine Market by Application
8.2.4 Canada Rabies Vaccine Market by Product Type
8.3 Mexico Rabies Vaccine Market
8.3.1 Mexico Rabies Vaccine Market by Prophylaxis Type
8.3.2 Mexico Rabies Vaccine Market by End User
8.3.3 Mexico Rabies Vaccine Market by Application
8.3.4 Mexico Rabies Vaccine Market by Product Type
8.4 Rest of North America Rabies Vaccine Market
8.4.1 Rest of North America Rabies Vaccine Market by Prophylaxis Type
8.4.2 Rest of North America Rabies Vaccine Market by End User
8.4.3 Rest of North America Rabies Vaccine Market by Application
8.4.4 Rest of North America Rabies Vaccine Market by Product Type

Chapter 9. Company Profiles
9.1 Cadila Pharmaceuticals Limited
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Product Launches and Product Expansions:
9.2 Bharat Biotech Ltd.
9.2.1 Company Overview
9.3 Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
9.3.1 Company Overview
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Elanco Animal Health, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 SWOT Analysis
9.6 Zoetis, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Merck & Co., Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Novartis AG
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Sanofi S.A.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Virbac
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 SWOT Analysis

TABLE 1 North America Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 2 North America Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 3 North America Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 4 North America Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 5 North America Post-exposure Prophylaxis Market by Region, 2019 - 2022, USD Million
TABLE 6 North America Post-exposure Prophylaxis Market by Region, 2023 - 2030, USD Million
TABLE 7 North America Pre-exposure prophylaxis Market by Region, 2019 - 2022, USD Million
TABLE 8 North America Pre-exposure prophylaxis Market by Region, 2023 - 2030, USD Million
TABLE 9 North America Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 10 North America Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 11 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 18 North America Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 19 North America Human Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Human Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Animal Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Animal Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 24 North America Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 25 North America Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 35 US Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 36 US Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 37 US Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 38 US Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 39 US Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 40 US Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 41 US Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 42 US Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 43 US Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 44 US Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 45 Canada Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 46 Canada Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 47 Canada Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 48 Canada Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 49 Canada Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 50 Canada Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 51 Canada Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 52 Canada Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 53 Canada Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 54 Canada Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 55 Mexico Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 56 Mexico Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 57 Mexico Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 58 Mexico Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 59 Mexico Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 60 Mexico Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 61 Mexico Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 62 Mexico Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 63 Mexico Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 64 Mexico Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 65 Rest of North America Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 66 Rest of North America Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 67 Rest of North America Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 68 Rest of North America Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 69 Rest of North America Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 70 Rest of North America Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 71 Rest of North America Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 72 Rest of North America Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 73 Rest of North America Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 74 Rest of North America Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 75 Key Information – Cadila Pharmaceuticals Limited
TABLE 76 Key Information – Bharat Biotech Ltd.
TABLE 77 Key Information – Serum Institute of India Pvt. Ltd.
TABLE 78 Key Information – Boehringer Ingelheim International GmbH
TABLE 79 Key information – Elanco Animal Health, Inc.
TABLE 80 Key Information – Zoetis, Inc.
TABLE 81 Key Information - Merck & Co., Inc.
TABLE 82 Key Information – Novartis AG
TABLE 83 Key Information – Sanofi S.A.
TABLE 84 Key Information – Virbac

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Rabies Vaccine Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Rabies Vaccine Market
FIG 4 Porter’s Five Forces Analysis – Rabies Vaccine Market
FIG 5 North America Rabies Vaccine Market share by Prophylaxis Type, 2022
FIG 6 North America Rabies Vaccine Market share by Prophylaxis Type, 2030
FIG 7 North America Rabies Vaccine Market by Prophylaxis Type, 2019 - 2030, USD Million
FIG 8 North America Rabies Vaccine Market share by End User, 2022
FIG 9 North America Rabies Vaccine Market share by End User, 2030
FIG 10 North America Rabies Vaccine Market by End User, 2019 - 2030, USD Million
FIG 11 North America Rabies Vaccine Market share by Application, 2022
FIG 12 North America Rabies Vaccine Market share by Application, 2030
FIG 13 North America Rabies Vaccine Market by Application, 2019 - 2030, USD Million
FIG 14 North America Rabies Vaccine Market share by Product Type, 2022
FIG 15 North America Rabies Vaccine Market share by Product Type, 2030
FIG 16 North America Rabies Vaccine Market by Product Type, 2019 - 2030, USD Million
FIG 17 North America Rabies Vaccine Market share by Country, 2022
FIG 18 North America Rabies Vaccine Market share by Country, 2030
FIG 19 North America Rabies Vaccine Market by Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 21 SWOT Analysis: Elanco Animal Health, Inc.
FIG 22 Swot Analysis: ZOETIS, INC.
FIG 23 SWOT Analysis: Merck & Co., Inc.
FIG 24 SWOT Analysis: Novartis AG
FIG 25 Swot Analysis: Sanofi S.A.
FIG 26 SWOT Analysis: Virbac